In an uncertainty market, investors often seek refuge in defensive actions that offer stability and resilience. Two of these pillars, Johnson & Johnson and Coca-Cola, embody the essence of investments safely. For investors who seek to resist the storm, these two giants offer the reassuring combination of security and the prospect of regular yields.
Are you looking for usable commercial ideas to navigate current market volatility? Subscribe here to unlock access to the investment of actions selected by AI.
Under turbulent market conditions, investors often turn to “boring” actions – these stable defensive games that offer stability and reliable yields even when wider markets are volatile.
Two of these actions are Johnson & Johnson (Nyse 🙂 and Coca-Cola (Nyse :), who both have a long history of delivery of coherent dividends, solid fundamentals and resilience in difficult times.
For investors who seek to resist the storm, these two giants offer the reassuring combination of security and the prospect of regular yields, which makes them ideal for priority investors The preservation of capital in the uncertain climate of February 2025.
1. Johnson & Johnson
Up to date year performance: + 13.2%
CATT-CAPPORT: 394.2 billion dollars
Johnson & Johnson is one of the largest health care companies in the world, operating through pharmaceutical products, medical devices and consumer health products. Its diversified commercial model and its strong global presence positioned the company as a defensive leader in the health care sector.
JNJ is currently $ 163.73, winning New Brunswick, New Jersey, a market value of $ 394.2 billion. Actions have increased by around 13% so far in 2025.
Source: Investing.com
During the market disorders, the defensive characteristics of J & J shine, which makes it a reliable investment for investors opposed to risk. Its strength lies in its large exposure to the market, its strong R&D capacities and a deep gap created by its diversified portfolio of successful brands.
Even in times of economic stress, the demand for essential health products remains relatively stable, …
..